Supermarkets across the U.S. are increasingly featuring meals and snacks labeled as “GLP-1 Friendly,” reflecting a growing interest in obesity drugs such as Wegovy and Zepbound. These medications, which mimic a naturally occurring hormone that controls appetite, are helping more Americans manage weight, prompting food companies to market products that appear to complement their use.
However, nutrition experts caution that these labels are not regulated by the U.S. Food and Drug Administration, unlike the drugs themselves. Dietitians emphasize that individuals taking GLP-1 medications must carefully review ingredient lists and seek professional guidance to ensure they meet their nutritional needs.
“A drug does not educate you on how to eat properly,” said Suzy Badaracco, a registered dietitian and president of the food trends firm Culinary Tides. “You’re not magically going to be educated — without a doctor’s help — to eat healthy.”
Nutritional Priorities for GLP-1 Users
According to Shannon Christen, a dietitian and diabetes educator at UCHealth University of Colorado Hospital, the nutritional needs of GLP-1 users are largely similar to the general population. The key difference is that these medications suppress appetite, meaning patients consume significantly smaller portions — sometimes 50% less than before — making every bite crucially important for nutrient intake.
Protein intake is particularly important for maintaining muscle mass during weight loss. Christen recommends around 20-30 grams of protein per meal or approximately 1.2 grams per kilogram of body weight per day. Fiber is another critical nutrient, especially since constipation is a common side effect of GLP-1 drugs. Samantha Snashall, a registered dietitian at Ohio State University’s Wexner Medical Center, advises meeting the USDA’s recommended fiber intake of 14 grams per 1,000 calories consumed.
Hydration is another concern, as GLP-1 medications can diminish the body’s thirst signals. Fresh fruits, vegetables, and adequate water consumption are recommended to counteract potential dehydration. Experts also advise avoiding deep-fried, high-sugar, high-fat, spicy, or acidic foods, which may exacerbate side effects and hinder weight-loss progress.
Food Companies Target GLP-1 Users
GLP-1 medications, including Ozempic and Wegovy, replicate the naturally occurring hormone GLP-1 that regulates appetite, digestion, and blood sugar. A Kaiser Family Foundation study found that approximately 12% of U.S. adults were using these medications as of November. As demand grows — particularly with Wegovy now available in pill form — food companies are adjusting their offerings.
Nestle, for instance, launched its Vital Pursuit frozen meal brand in late 2024. While the brand initially lacked GLP-1 labeling, customer feedback prompted the company to add a “GLP-1 Friendly” label to help shoppers identify meals aligned with their dietary needs, according to Jennifer Barnes, vice president of brand marketing for Nestle’s frozen meals. Surprisingly, 77% of Vital Pursuit sales come from households with no GLP-1 users, highlighting the broader appeal of nutrient-focused products.
Other brands have followed suit. Conagra Brands added GLP-1 Friendly labels to 26 Healthy Choice frozen meals in early 2025. Smoothie King introduced a “GLP-1 Support Menu,” and meal-kit services like Factor market “GLP-1 Balance” options. These labels received USDA Food Safety and Inspection Service approval because they include clear statements on protein and fiber content, though the agency notes there is no official regulatory standard for “GLP-1 Friendly.”
Label Limitations and Consumer Caution
Experts warn that packaged foods marketed as GLP-1 Friendly may not always be as healthy as they seem. High levels of sodium, sugar, or fat can undermine both nutrition and weight-loss goals. Christen cites examples such as Vital Pursuit’s Cauliflower Crust Three Meat Pizza, which delivers high protein but also excessive fat and sodium, and Smoothie King’s Gladiator GLP-1 Vanilla smoothie, which can contain more calories, sodium, and cholesterol than a glazed donut.
“Done responsibly, these labels could help people make smart choices,” Christen said. “Done poorly, they can trivialize medical treatment and drift into diet culture marketing.”
Badaracco advises food companies to avoid using the GLP-1 term on packaging. Instead, labels should highlight clear nutritional benefits, like protein, fiber, hydration, and energy support, which are universally helpful regardless of drug use.
“Consumers are looking for tangible benefits,” she said. “It’s about what the food provides, not just its compatibility with a medication.”
